uBriGene Biosciences

Biotechnology Research • 20400 Century Blvd, Germantown, United States • 21-50 Employees

Company overview

Headquarters	20400 Century Blvd, Germantown, Maryland 20874, US
Phone number	+1120813351
Websites	ubrigene.com ymcell.com
Keywords	Aseptic Fill And Finish, Oncolytic Virus, Clinical Applications, Viral Vector, Rna-Lnp, Aav / Lvv Helper Plasmids, Analytical Development And Testing, Car-Tcr / Car-Nk / Til, Cro Services (Plasmids, Cas9 Proteins / Mrna, Gmp Aav, Gmp Cell Therapies, Gmp Exosome, Gmp Lentivirus, Gmp Plasmids, Gmp Rna-Lnp, Gmp Viral Vectors, Gmp Sgrna Ivt, Ipsc / Msc, Ipsc Banks, Ipsc Reprogramming Rna-Lnp, Mrna / Circrna / Sarna, Sgrna Ivt)
Founded	2015
Employees	21-50
Socials

Key Contacts at uBriGene Biosciences

Jane Shao

Regional Hr Director, North America

Scott Pattison

Sr. Director Business Development

Gang Liu

Qc Director

Mingjuan Liu

Director Of Marketing, North America

Mark Sye

Director Of Quality Assurance

Boon Hwa Neo

Associate Director Of Msat

uBriGene Biosciences Email Formats

uBriGene Biosciences uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@ubrigene.com), used 46.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@ubrigene.com	46.7%
{first name}.{last name}	john.doe@ubrigene.com	40%
{first initial}{last name}	jdoe@ubrigene.com	13.3%

About uBriGene Biosciences

uBriGene Biosciences is your bridge from ATMPs concept to commercialization. Our CDMO+ services include cell therapy products (CAR-T, TCR-T, NK Cells, iPSC, Dendritic cells, Macrophages), viral vectors (AAV, LVV, RVV, AdV, oncolytic viruses), plasmids, and RNA (mRNA, circRNA, acRNA). Our extensive experience in manufacturing, QC testing, and regulatory filing support of ATMPs, from early discovery to commercialization, will accelerate your therapeutic programs from bench to bedside. With four Centers of Excellence in North America, and Asia Pacific and more than 20 GMP clean room suites, uBriGene supports global CGT, vaccine, and RNA product development.

uBriGene Biosciences revenue & valuation

Annual revenue	$10,000,000
Revenue per employee	$477,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$32,000,000
Total funding	$76,600,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

Vice President

Employees by Department

uBriGene Biosciences has 10 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore uBriGene Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-05-19	6	$21,800,000
2025-01-24	6	$27,400,000
2025-01-24	7	$27,400,000

Funding Insights

$76,600,000

Total funding amount

$27,400,000

Most recent funding amount

Number of funding rounds

uBriGene Biosciences Tech Stack

Discover the technologies and tools that power uBriGene Biosciences's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Gravity Forms

Form builders

CivicTheme

UI frameworks

WP Rocket

Caching

Oxygen

Page builders

Microsoft 365

Cloudflare

CDN

jQuery

JavaScript libraries

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

Frequently asked questions

uBriGene Biosciences is located in 20400 Century Blvd, Germantown, US.

You can reach uBriGene Biosciences at +1120813351.

uBriGene Biosciences was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

uBriGene Biosciences has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

uBriGene Biosciences has raised a total of $76,600,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.